The future of human longevity: regenerative medicine in focus

10 Jan 2013

Location: swissnex China, Consulate General of Switzerland, Shanghai

About the event

Swiss Re, one of the world’s largest re/insurers, in collaboration with swissnex China, one of five Swiss science and technology consulates worldwide, cordially invite you to this half-day conference, to be held at swissnex China, Consulate General of Switzerland in Shanghai, China.


Thirty years ago, the actuarial tables did not predict we would live this long. That has repercussions, particularly when combined with a low birth rate. Swiss Re is seeking to improve understanding of future longevity trends. As such, we will be addressing regenerative medicine approaches in treating some of the key morbidities of human kind. The event will address the following:

  • Historical perspective of stem cell therapy
  • Regenerative medicine in the brain and central nervous system
  • Learnings from animal models for treating Parkinson's
  • Role of stem stells in diabetes

Target audience

Swiss Re insurance industry clients heading mortality and longevity research / pricing unit, and leading experts in fields spanning epidemiology, the aging process, and cutting edge advances in the prevention, detection and treatment of disease.

Note: This event may be photographed, filmed and /or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on the Centre's, Swiss Re’s and swissnex China's internal and external websites and in printed materials.


Thursday, 10 January 2013

Times indicated are for China Standard Time (CST)


Welcome coffee and registration


Pascal Marmier, Director, swissnex China
Daniel Ryan, Head Life & Health R&D, Swiss Re


Primer: an insurer's view on longevity
Hengchang Pan, Regional Product Actuary Life & Health, Swiss Re


Historical perspective of stem cell research and regenerative medicine
Urs Widmer, Senior Medical Officer, Swiss Re


Brain and eye regenerative medicine
ZHU Jianhong, Principal Investigator, Professor of Neurosurgery, Fudan University Huashan Hospital; Deputy Director, National Key Laboratory for Medical Neurobiology


Coffee break


Our interest in regenerative medicine - using diabetes as a case study
Daniel Ryan, Head Life & Health R&D, Swiss Re


Parkinson's disease
CHEN Shengdi, Professor & Chairman, Department of Neurology & Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine


Closing remarks
Daniel Ryan, Head Life & Health R&D, Swiss Re


Networking reception





Registration for this event has expired.